These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 26108730

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y, Zhang H, Li Y, Li Q, Zuo L.
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [Abstract] [Full Text] [Related]

  • 3. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Neven E, Vervaet B, Brand K, Gottwald-Hostalek U, Opdebeeck B, De Maré A, Verhulst A, Lalau JD, Kamel S, De Broe ME, D'Haese PC.
    Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease.
    Carrillo-López N, Panizo S, Alonso-Montes C, Martínez-Arias L, Avello N, Sosa P, Dusso AS, Cannata-Andía JB, Naves-Díaz M.
    Nephrol Dial Transplant; 2019 Jun 01; 34(6):934-941. PubMed ID: 30189026
    [Abstract] [Full Text] [Related]

  • 6. High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats.
    Bisson SK, Ung RV, Picard S, Valade D, Agharazii M, Larivière R, Mac-Way F.
    J Bone Miner Metab; 2019 Mar 01; 37(2):212-223. PubMed ID: 29603070
    [Abstract] [Full Text] [Related]

  • 7. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
    Tatsumoto N, Yamada S, Tokumoto M, Eriguchi M, Noguchi H, Torisu K, Tsuruya K, Kitazono T.
    Am J Physiol Renal Physiol; 2015 Dec 01; 309(11):F967-79. PubMed ID: 26336165
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism.
    Yu L, Tomlinson JE, Alexander ST, Hensley K, Han CY, Dwyer D, Stolina M, Dean C, Goodman WG, Richards WG, Li X.
    Calcif Tissue Int; 2017 Dec 01; 101(6):641-653. PubMed ID: 29038882
    [Abstract] [Full Text] [Related]

  • 13. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease.
    McCabe KM, Booth SL, Fu X, Shobeiri N, Pang JJ, Adams MA, Holden RM.
    Kidney Int; 2013 May 01; 83(5):835-44. PubMed ID: 23344475
    [Abstract] [Full Text] [Related]

  • 14. Mineral bone disorders in chronic kidney disease.
    Hou YC, Lu CL, Lu KC.
    Nephrology (Carlton); 2018 Oct 01; 23 Suppl 4():88-94. PubMed ID: 30298663
    [Abstract] [Full Text] [Related]

  • 15. Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels.
    Terai K, Nara H, Takakura K, Mizukami K, Sanagi M, Fukushima S, Fujimori A, Itoh H, Okada M.
    Br J Pharmacol; 2009 Apr 01; 156(8):1267-78. PubMed ID: 19302594
    [Abstract] [Full Text] [Related]

  • 16. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Apr 01; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 17. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.
    Shalhoub V, Shatzen EM, Ward SC, Davis J, Stevens J, Bi V, Renshaw L, Hawkins N, Wang W, Chen C, Tsai MM, Cattley RC, Wronski TJ, Xia X, Li X, Henley C, Eschenberg M, Richards WG.
    J Clin Invest; 2012 Jul 01; 122(7):2543-53. PubMed ID: 22728934
    [Abstract] [Full Text] [Related]

  • 18. Osteogenesis of heterotopically transplanted mesenchymal stromal cells in rat models of chronic kidney disease.
    Kramann R, Kunter U, Brandenburg VM, Leisten I, Ehling J, Klinkhammer BM, Knüchel R, Floege J, Schneider RK.
    J Bone Miner Res; 2013 Dec 01; 28(12):2523-34. PubMed ID: 23703894
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Site-specific chelation therapy with EDTA-loaded albumin nanoparticles reverses arterial calcification in a rat model of chronic kidney disease.
    Karamched SR, Nosoudi N, Moreland HE, Chowdhury A, Vyavahare NR.
    Sci Rep; 2019 Feb 22; 9(1):2629. PubMed ID: 30796300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.